teaser
review
provid
updat
recent
advanc
intracellular
deliveri
report
mechan
could
help
drug
reach
target
effici
result
smarter
drug
reach
target
still
origin
bioavail
intracellular
deliveri
nanomateri
drug
attract
increas
research
interest
mainli
import
effect
function
sever
organel
target
specif
organel
help
treat
decreas
symptom
diabet
cancer
infecti
autoimmun
diseas
tune
biolog
chemic
properti
enabl
creation
function
nanomateri
enhanc
intracellular
uptak
abil
escap
prematur
lysosom
degrad
reach
specif
target
provid
updat
recent
advanc
intracellular
deliveri
mechan
could
help
drug
reach
target
effici
develop
nanomedicin
deliveri
provid
new
perspect
design
synthesi
effici
nanocarri
multifunct
nanomateri
initi
research
focus
nanocarri
biocompat
toxic
wherea
secondgener
nanomateri
aim
optim
surfac
provid
stabil
stealth
target
capabl
recent
model
support
smart
nanomedicin
idea
improv
target
mechan
theranost
abil
nanotechnolog
advanc
import
enabl
drug
cross
physiolog
barrier
reach
target
site
safe
sustain
fact
nanomateri
provid
stabl
biocompat
environ
encapsul
drug
promot
control
releas
effici
absorpt
also
improv
durat
therapeut
effect
minim
advers
effect
drive
drug
toward
site
action
increas
concentr
drug
area
patholog
specif
way
depend
accumul
deliveri
system
tissu
cell
specif
subcellular
compart
interest
target
approach
primari
secondari
tertiari
respect
subcellular
target
vital
effici
specif
treatment
thu
specif
barrier
must
overcom
import
organel
target
increas
drug
effici
treat
also
current
visit
professor
postgradu
school
unioest
brazil
far
co
supervisedcosupervis
numer
student
publish
extens
intern
peerreview
isi
journal
book
confer
proceed
also
given
present
nation
intern
meet
award
sever
distinct
dr
sarmento
current
research
focus
develop
function
nanomedicin
applic
pharmaceut
biomed
field
particular
interest
nanoformul
biopharmaceut
drug
use
diabet
cancer
infecti
diseas
also
special
mucos
tissu
engin
model
valid
function
nanomedicin
perform
vitroin
vivo
correl
far
supervisedcosupervis
postdoc
phd
student
complet
msc
student
complet
research
assist
publish
paper
intern
peer
review
isi
journal
top
journal
pharmaceut
scienc
nanosci
nanotechnolog
total
citat
hindex
book
chapter
proceed
edit
book
particip
invit
select
talk
nation
intern
meet
award
sever
distinct
current
research
focus
develop
function
nanomedicin
applic
pharmaceut
biomed
field
particular
nanoformul
biopharmaceut
drug
interest
diabet
cancer
infecti
diseas
also
special
mucos
tissu
engin
model
valid
function
nanomedicin
perform
vitroin
vivo
correl
decreas
symptom
diseas
cancer
alzheim
diabet
infecti
autoimmun
diseas
specif
intracellular
environ
contain
compound
respons
cell
growth
prolifer
differenti
death
therefor
promis
drug
target
thu
target
site
distribut
throughout
cytoplasm
nucleu
mitochondria
endoplasm
reticulum
er
golgi
complex
howev
endosom
lysosom
low
ph
rich
enzym
result
drug
degrad
nonspecif
distribut
thu
modul
size
charg
surfac
composit
nanomateri
dictat
intern
pathway
enabl
nanomateri
evad
lysosom
interact
target
organel
inde
potenti
nanomateri
overcom
barrier
led
develop
platform
capabl
improv
bioavail
therefor
need
fulli
understand
pathway
nanomateri
uptak
intracellular
mechan
creat
smarter
drug
reach
target
site
origin
bioavail
review
step
drug
administr
target
site
identifi
challeng
must
overcom
success
drug
deliveri
review
help
research
design
effici
nanomateri
result
enhanc
drug
uptak
three
fundament
step
product
nanomateri
drug
deliveri
must
taken
account
nanomateri
must
abl
surviv
harsh
condit
gastrointestin
tract
git
intern
must
reach
target
site
pharmacokinet
drug
must
maintain
nanomateri
administr
sever
rout
oral
rout
conveni
howev
effici
oral
deliveri
nanomateri
must
pass
oral
caviti
rich
protein
mucos
compound
bacteri
flora
follow
stomach
highli
acid
final
intestin
nanomateri
subject
activ
digest
enzym
presenc
mucu
layer
form
glycoprotein
mucin
tight
junction
tj
cross
endotheli
barrier
nanomateri
reach
blood
taken
unspecif
phagocyt
cell
specif
target
cell
addit
target
site
drug
distribut
throughout
cytoplasm
nucleu
mitochondria
lysosom
git
main
barrier
success
absorpt
nanomateri
particularli
term
drug
degrad
enzym
proteolyt
enzym
lysosom
brushbord
peptidas
villi
pancreat
proteas
duoden
region
bacteri
flora
within
gut
also
contain
mucin
epitheli
cell
also
constitut
physiolog
barrier
bond
tj
nanomateri
modifi
physicochem
respons
low
ph
high
temperatur
reaction
surround
molecul
addit
chang
weight
charg
nanomateri
also
influenc
absorpt
degrad
addit
barrier
intestin
epithelium
control
passag
drug
blood
surfac
area
cover
enterocyt
microvilli
signific
impact
absorpt
morpholog
intestin
crypt
compris
absorpt
enterocyt
secretori
cell
eg
goblet
cell
enteroendocrin
cell
paneth
cell
addit
isol
lymphoid
follicl
peyer
patch
contain
special
cell
lastli
reach
target
site
origin
bioavail
retain
nanomateri
must
overcom
mononuclear
phagocyt
system
avoid
becom
nonspecif
distribut
lead
drug
resist
escap
endosom
discuss
indepth
mononuclear
phagocyt
system
overcom
modul
certain
characterist
nanomateri
nonspecif
distribut
avoid
use
function
addit
biomimet
surfac
drug
efflux
pump
consequ
drug
resist
avoid
use
target
drug
escap
endosom
disrupt
membran
reach
target
cell
intern
nanomateri
involv
set
process
includ
preabsorpt
uptak
transloc
reach
final
target
initi
nanomateri
activ
transport
cell
via
receptor
recognit
ligand
contain
sever
possibl
pathway
intern
nanomateri
focu
paracellular
pathway
endocytosi
pathway
use
nonfunction
function
nanomateri
paracellular
rout
mainli
exploit
nanomateri
particular
natur
size
absenc
receptor
nanomateri
transport
two
juxtapos
cell
via
aquaporin
tj
aquaporin
protein
facilit
water
transport
across
lumin
space
basolater
membran
wherea
tj
maintain
structur
integr
membran
tj
gap
cell
contain
occludin
protein
aid
paracellular
transport
permeabl
presenc
tj
low
surfac
area
limit
transport
nanomateri
pass
intestin
barrier
via
rout
tj
must
revers
open
chemic
modifi
nanomateri
use
permeat
enhanc
chitosan
polyacryl
thiolat
polym
anion
cation
polym
thu
paracellular
pathway
mainli
transport
hydrophil
drug
recent
studi
use
cation
cyclodextrinpolyethylenimin
conjug
complex
anion
mrna
encod
hiv
open
tj
enhanc
paracellular
transport
nanomateri
thiolat
polym
known
thiomer
hydrophil
polym
conjug
hydrophil
macromolecul
enhanc
uptak
thiomer
abil
mimic
mechan
secret
mucu
glycoprotein
coval
bind
disulfid
bond
cystein
mucu
enhanc
mucoadhes
inhibit
enzym
action
thu
thiomer
remain
concentr
absorpt
membran
result
protect
thiol
group
efflux
inhibit
thiomer
reduc
oxid
glutathion
gssg
gsh
time
thiol
group
oxid
disulfid
bond
attach
nanomateri
mucosa
glycoprotein
gsh
bind
cystein
activ
site
protein
tyrosin
phosphatas
ptp
via
disulfid
bond
prevent
ptp
remov
phosphat
group
tyrosin
residu
result
tj
open
improv
permeat
properti
nanomateri
facilit
diffus
earli
studi
show
ptp
inhibit
use
sodium
orthovanad
led
tyrosin
phosphoryl
tj
improv
permeabl
bovin
corneal
epitheli
cell
tj
respons
uptak
hydrophil
nanomateri
throughout
paracellular
rout
associ
thiomer
increas
appar
permeabl
contrast
function
nonfunction
nanomateri
typic
endocytos
endocytosi
involv
engulf
membran
invagin
format
intracellular
vesicl
pathway
repres
classic
mechan
nanomateri
uptak
divid
five
type
even
nanomateri
alreadi
insid
cell
drug
pump
via
drug
efflux
pump
result
drug
resist
phagocytosi
receptormedi
process
larg
particl
engulf
cellular
membran
limit
macrophag
dendrit
cell
cell
contrast
pinocytosi
uptak
fluid
solut
subclassifi
macropinocytosi
clathrinand
caveolaemedi
uptak
clathrinand
caveolaeindepend
uptak
macropinocytosi
larg
volum
fluid
contain
nanomateri
engulf
activ
actindepend
process
thu
requir
actin
grow
cholesterol
extend
membran
also
nonspecif
receptor
mediat
thu
requir
specif
ligandreceptor
bind
specif
cellular
type
howev
cellular
stimul
requir
initi
process
clathrinmedi
endocytosi
receptormedi
uptak
mechan
control
dynamin
dynamin
gtpase
protein
lead
divis
clathrin
pit
membran
result
format
small
vesicl
nm
coat
clathrin
intern
clathrin
remov
auxilin
vesicl
fuse
earli
endosom
mechan
seen
housekeep
mechan
degrad
unwant
protein
maintain
cellular
homeostasi
rout
usual
involv
lowdens
lipoprotein
transferrin
ligandreceptor
complex
pharmacolog
inhibitor
use
analyz
topolog
endocytosi
steinbach
cowork
use
chlorpromazin
specif
clathrin
nystatin
specif
caveolin
specif
macropinocytosi
show
clathrinmedi
endocytosi
predomin
mechan
effect
protein
corona
surround
nanoparticl
corona
constitut
primari
nanobiointerfac
determin
fate
nanoparticl
deleteri
effect
interact
protein
preexist
initi
materi
characterist
contribut
format
corona
biolog
environ
characterist
protein
attach
andor
detach
rate
competit
bind
interact
steric
hindranc
deterg
adsorb
polym
protein
profil
bodi
fluid
lead
dynam
chang
corona
corona
chang
particl
move
one
biolog
compart
anoth
reproduc
permiss
ref
intern
nanoparticl
np
studi
yet
nanomateri
decor
certain
ligand
folic
acid
cholesterol
caveolinmedi
endocytosi
mechan
use
demonstr
use
albumin
chanthick
colleagu
small
caveolaeco
vesicl
nm
also
control
dynamin
form
flaskshap
invagin
nonspecif
uptak
process
therefor
caveolin
integr
membran
protein
respons
format
caveola
consequ
format
invagin
express
morpholog
function
differ
depend
cell
type
intern
caveola
endocytos
togeth
vesicl
caveola
similar
lipid
raft
also
compris
cholesterol
sphingolipid
well
glycosylphosphatidylinositol
gpi
sever
kinas
contrast
clathrin
caveolaemedi
endocytosi
requir
signal
begin
endocytosi
start
tyrosin
phosphoryl
associ
protein
lead
depolymer
enlist
actin
lead
escap
endolysosom
direct
exocytosi
drug
carrier
final
clathrinand
caveolinindepend
transport
occur
via
nonspecif
endocytosi
without
need
receptor
also
character
dynamin
inand
depend
pathway
case
eipa
usual
use
transport
inhibitor
recent
promis
biomanufactur
advanc
intracellular
deliveri
nanomateri
microfluid
membran
disrupt
method
microfluid
technolog
improv
qualiti
deliveri
system
establish
structurefunct
relationship
nanomateri
addit
advantag
uniforms
emuls
droplet
understand
intracellular
deliveri
barrier
howev
yet
clear
whether
possibl
scaleup
system
wholebodi
use
microfluid
devic
pass
singl
cell
creat
transient
pore
plasmat
membran
enhanc
intracellular
deliveri
via
mechanopor
effici
alreadi
demonstr
intracellular
deliveri
np
load
dexamethason
author
also
studi
effect
np
design
fate
stem
cell
other
use
approach
prevent
rapid
clearanc
consequ
loss
microbubbl
use
flowfocus
microfluid
devic
real
time
near
therapeut
site
intern
intracellular
transport
mechan
affect
properti
nanomateri
use
fig
differ
characterist
size
charg
shape
elast
affect
interact
nanomateri
cell
membran
caus
alter
signal
event
activ
differ
pathway
adhes
intern
thu
desir
result
effect
specif
target
deliveri
predetermin
rate
time
obtain
control
paramet
size
vital
paramet
determin
endocytosi
pathway
cell
take
particl
particl
nm
mainli
remov
renal
clearanc
oral
administr
particl
higher
cellular
uptak
effici
taken
peyer
patch
absorb
system
circul
avoid
rapid
renal
clearanc
contrast
larger
particl
remov
mononuclear
phagocyt
system
mp
nm
becom
concentr
spleen
intern
larger
particl
mm
enter
cell
via
macropinocytosi
nm
enter
via
clathrindepend
pathway
nm
enter
via
caveolaedepend
pathway
smaller
particl
nm
intern
via
clathrinand
caveolaeindepend
pathway
thu
intern
nanomateri
correl
size
vacuol
form
penetr
enhanc
ad
macromolecul
high
molecular
weight
dimethyl
palmitoyl
ammonio
propanesulfon
pp
zwitterion
surfact
accord
microscopi
studi
pp
allow
macromolecul
diffus
via
paracellular
transcellular
pathway
improv
bioavail
addit
polyacryl
chitosan
phytic
acid
selfassembl
lipidlik
peptid
also
work
enhanc
well
thiomer
lectin
enhanc
abil
revers
open
tj
increas
paracellular
transport
macromolecular
drug
downregul
occludin
claudin
tj
protein
synerg
reduct
effect
ca
term
latter
cation
bind
affin
polyacryl
deriv
inhibit
lumen
enzym
eg
trypsin
thu
polyacrylateca
complex
trigger
open
tj
also
demonstr
cyclodextrin
improv
macromolecular
absorpt
via
pulmonari
deliveri
final
altern
strategi
use
palmitoyl
glycol
chitosan
hydrogel
develop
liposom
enhanc
deliveri
hydrophil
macromolecul
surfac
nanomateri
also
import
contact
cell
contact
affect
hydrophob
hydrophil
nanomateri
surfac
thu
paramet
determin
cellular
intern
intracellular
transport
influenc
circul
time
nanocarri
associ
recognit
cell
hydrophob
particl
deliv
immun
cell
penetr
bilay
membran
becom
easili
intern
polym
ad
nanomateri
render
surfac
inert
hydrophil
avoid
immun
clearanc
increas
blood
circul
time
poli
ethylen
glycol
peg
ylation
strategi
render
nanomateri
invis
macrophag
phagocyt
prolong
halflif
peg
chain
coval
conjug
nanomateri
render
hydrophil
peg
captur
water
molecul
form
natur
barrier
around
nanomateri
prevent
protein
adsorb
known
stealth
effect
anoth
strategi
use
biomimet
surfac
wherebi
nanomateri
surfac
modifi
natur
membran
coat
avoid
phagocyt
clearanc
prolong
drug
circul
improv
biocompat
marker
even
leukocyt
attach
surfac
nanomateri
camouflag
bodi
recogn
self
surfac
charg
nanomateri
also
manipul
exampl
intestin
cell
membran
neg
charg
presenc
phospholipid
thu
posit
charg
nanomateri
interact
strongli
membran
enhanc
intern
typic
exampl
polyethyleneimin
pei
commonli
use
permeat
membran
enabl
nanomateri
enter
cell
term
transport
posit
charg
particl
util
clathrinmedi
pathway
macropinocytosi
wherea
neg
charg
particl
tend
util
caveolaemedi
pathway
neutral
slightli
neg
charg
particl
consid
appropri
long
circul
suscept
mp
contrast
nanomateri
highli
posit
neg
charg
taken
macrophag
shape
also
dictat
path
nanomateri
chang
time
receiv
extern
stimuli
enabl
long
circul
overcom
diffus
barrier
import
factor
flow
margin
avoid
immun
system
tissu
accumul
spheric
particl
better
intern
macrophag
wherea
asymmetr
nanomateri
advantag
sens
selfassembl
tissu
engin
immunoengin
therapeut
diagnost
deliveri
thu
one
strategi
creat
ellipt
particl
escap
macrophag
expos
stimulu
chang
sphere
improv
intern
final
increas
elast
also
increas
blood
resid
time
avoid
clearanc
immun
system
elast
nanomateri
use
macropinocytosi
wherea
less
elast
one
intern
via
clathrindepend
mechan
anoth
popular
method
chemic
modifi
nanomateri
chang
fluiditi
andor
solubl
mucu
oral
administr
exampl
possibl
add
fatti
acid
substitut
amino
acid
obtain
increas
solubl
addit
fatti
acid
proport
increas
solubl
increas
linol
acid
similar
effect
also
observ
capric
lauric
oleic
acid
fatti
acid
increas
hydrophil
transport
reduc
transepitheli
electr
resist
indic
open
tj
paracellular
transport
relat
sever
paper
transport
poorli
absorb
drug
studi
reveal
relat
paracellular
transport
fatti
acid
effect
absorpt
mannitol
paracellular
marker
morpholog
chang
tj
research
ad
amino
acid
ribonucleas
rnase
sa
posit
confirm
asparagin
glutamin
threonin
signific
effect
protein
solubl
short
variou
characterist
tabl
influenc
uptak
renal
clearanc
drug
stabil
circul
time
nanomateri
well
drug
releas
properti
even
chang
via
intern
ph
redox
temperatur
enzym
extern
stimuli
ultrasound
magnet
light
electr
stimulirespons
nanocarri
alreadi
review
elsewher
smart
approach
intracellular
drug
deliveri
recent
author
inclus
creat
porou
silica
nanocarri
sensit
three
stimuli
proteas
redox
ph
drug
deliveri
blanco
cowork
summar
main
effect
np
size
shape
surfac
charg
among
differ
organ
includ
lung
liver
spleen
kidney
also
necessari
analyz
presenc
nanomateri
target
tissu
organ
current
possibl
use
method
magnet
reson
ultrasound
fluoresc
positron
emiss
tomographi
pet
phosphoresc
xray
optic
coher
tomographi
photoacoust
raman
fluoresc
photoacoust
approach
contrast
intracellular
deliveri
sens
electrochemistri
electrophysiolog
method
review
elsewher
manipul
differ
characterist
nanomateri
help
function
nonfunction
nanomateri
reach
target
discuss
nonfunction
nanomateri
less
specif
carrier
specif
target
limit
function
well
render
less
stabl
howev
carrier
deliveri
drug
cell
case
nanocryst
np
macromolecul
taken
cell
enterocyt
intestin
epithelium
even
phagocyt
nonfunction
nanomateri
usual
use
neg
control
function
nanomateri
nanocryst
solid
particl
form
set
atom
structur
aspect
ratio
cellulos
nanocryst
cnc
elong
rigid
form
acid
hydrolysi
cellulos
nanocryst
abil
load
high
amount
drug
make
ideal
way
obtain
pharmacolog
effect
cnc
pei
develop
deliveri
small
interf
si
rna
gene
silenc
antitumor
strategi
formul
protect
sirna
facilit
deliveri
tumor
cell
via
endosom
escap
proton
spong
effect
anoth
studi
effect
unmodifi
cnc
cation
deriv
evalu
mitochondria
stress
author
reveal
compound
induc
reactiv
oxygen
speci
ro
product
immun
respons
benefici
effect
nonfunction
cnc
also
demonstr
ad
blactoglobulin
prolong
stabil
low
ph
addit
surfac
ph
influenc
affin
agglomer
aggreg
nanomateri
accord
result
surfac
ph
affect
phagocytosi
cellular
homeostasi
wherebi
abl
trigger
inflammatori
respons
acid
ph
wherea
basic
ph
suppress
releas
cytokin
term
cellular
intern
nanocryst
enter
cell
passiv
diffus
even
endocytosi
np
nm
nontox
safe
carrier
divid
inorgan
eg
porou
np
silica
np
carbon
nanotub
gold
np
aunp
quantum
dot
iron
oxid
np
organ
eg
liposom
drugpolym
conjug
micel
polymer
np
dendrim
proteinpolym
conjug
fig
instanc
porou
np
character
high
load
capac
chemic
physic
robust
low
toxic
easi
cheap
product
divid
mesopor
silica
np
msn
porou
silicon
np
psinp
type
possibl
avoid
prior
releas
drug
control
bind
affin
cargo
gatekeep
eg
aunp
attach
pore
outlet
via
coval
bond
broken
extern
appli
stimulu
eg
light
magnet
field
ultrasound
temperatur
intern
stimulu
inher
treat
patholog
exclud
acid
basic
environ
presenc
enzym
instanc
silicaencapsul
solid
lipid
sesl
particl
develop
cinnarizin
cin
deliveri
overcom
limit
oral
absorpt
weakli
basic
drug
ph
depend
intestin
condit
anoth
exampl
inorgan
np
qd
rapidli
taken
macrophag
abil
move
around
cytoplasm
target
nuclear
histon
via
nuclear
pore
complex
despit
small
size
nm
abil
due
charg
associ
qd
qd
also
theranost
show
potenti
promot
drug
deliveri
cell
exampl
inorgan
organ
nanoparticl
use
medicin
adapt
permiss
ref
wwwdrugdiscoverytodaycom
intracellular
drug
deliveri
demonstr
nonfunction
aunp
wherebi
unmodifi
aunp
ie
without
surfac
modif
shown
interact
cytoplasm
pancreat
tumor
cell
alter
charg
surfac
characterist
np
maxim
intern
intracellular
transport
cation
liposom
effect
previous
studi
frequent
choic
gene
deliveri
recent
studi
combin
protein
cation
liposom
improv
effici
plasmid
dna
pdna
deliveri
nucleu
mammalian
cell
liposom
main
nonvir
vector
produc
pdna
deliveri
cell
via
macropinocytosi
liposom
compris
nm
lamellar
phospholipid
bilay
hydrophil
center
hydrophob
part
membran
contain
amphiphil
molecul
liposom
taken
monocyt
macrophag
advantag
aim
modul
immun
howev
occasion
induc
complement
activ
lead
hypersensit
reaction
polymer
np
solid
colloid
particl
drug
entrap
encapsul
absorb
biocompat
polymer
materi
improv
drug
absorpt
across
biolog
membran
polymer
materi
biodegrad
poli
lactid
pla
poli
lactidecoglycolid
copolym
plga
poli
ecaprolacton
pcl
poli
amino
acid
nonbiodegrad
poli
methyl
methacryl
pmma
polyacrylamid
polystyren
polyacryl
natur
chitosan
dextran
heparin
algin
gelatin
albumin
polymer
np
wide
use
drug
deliveri
sever
cell
includ
macrophag
also
abl
reach
organel
mitochondria
nucleu
appear
promis
strategi
use
treat
inflammatori
bowel
diseas
diabet
cancer
ophthalmolog
condit
drugpolym
conjug
polymer
np
conjug
drug
via
either
direct
coval
linkag
noncoval
interact
normal
two
compon
connect
stabl
cleavabl
linker
especi
drug
reach
intracellular
target
conjug
recent
studi
liang
et
al
provid
exampl
stabl
polymerdrug
conjug
enhanc
anticanc
effect
treat
colon
cancer
author
chemic
conjug
amin
group
gemcitabin
gem
difluorodeoxycytidin
pla
carboxyl
acid
group
methoxi
pegpla
polym
block
peg
avoid
protein
absorpt
defens
system
bodi
hydrophob
pla
render
conjug
biocompat
biodegrad
nontox
micel
organ
np
compris
amphiphil
copolym
nm
usual
form
selfassembl
liquid
hydrophil
shell
prevent
interact
solvent
render
load
micel
stabl
aqueou
solut
hydrophob
core
hold
therapeut
drug
molecul
micel
attract
interest
drug
administr
owe
high
stabil
solubil
capac
hydrophil
shell
control
drug
releas
low
toxic
recent
studi
propos
micel
formul
plgapegplga
prevent
cancer
metastasi
author
show
deriv
ursol
acid
act
anticanc
agent
induc
apoptosi
target
nucleu
mitochondria
cancer
cell
despit
size
macromolecul
also
diffus
across
membran
shown
exampl
across
skin
layer
deliveri
also
achiev
extern
stimulu
instanc
control
releas
achiev
use
nearinfrar
nir
light
irradi
aunp
associ
macromolecul
lightrespons
microcapsul
result
heat
disrupt
capsul
also
way
deliveri
macromolecul
mechanopor
pore
form
enabl
access
common
strategi
conjug
macromolecul
mucoadhes
polym
chitosan
open
tj
facilit
paracellular
transport
mechan
nonfunction
nanomateri
intern
yet
well
establish
studi
requir
therefor
use
function
nanomateri
altern
approach
sever
biomed
applic
function
nanomateri
direct
specif
target
improv
effect
minim
advers
effect
drive
drug
toward
exact
site
action
upgrad
absorpt
distribut
metabol
excret
adm
properti
enhanc
therapeut
effici
activ
target
nanomateri
refer
drug
reach
right
target
via
sitespecif
target
mean
interact
target
ligand
nanocarri
receptor
cell
membran
recognit
specif
promot
particl
intern
thu
modifi
surfac
nanomateri
particular
ligand
one
way
improv
cellular
uptak
endosom
escap
tabl
summar
receptor
target
approach
includ
integrin
transferrin
integrin
transferrin
egfr
igfr
fcrn
biotin
folat
vitamin
b
cellpenetr
peptid
cpp
group
peptid
amino
acid
abil
promot
molecular
transport
import
enhanc
intracellular
uptak
cpp
conjug
via
coval
bind
protein
drug
believ
endocytosi
involv
transloc
given
typic
posit
charg
cpp
glycosaminoglycan
gag
sialic
acid
interact
electrostat
neg
charg
cell
glycosaminoglycan
gag
sialic
acid
begin
transloc
cppadaptor
fusion
protein
tatcalmodulin
tatcam
develop
result
effici
intracellular
deliveri
endosom
escap
exampl
revers
highaffin
noncoval
bind
deliv
cargo
cytoplasm
eukaryot
cell
research
use
analog
cpp
conjug
np
transport
sirna
conclud
ph
chang
lead
effici
deliveri
given
posit
charg
respons
stabil
complex
anoth
approach
nanomateri
function
drug
conjug
lectin
nonimmunolog
origin
facilit
interact
cell
drug
diffus
given
contain
glycan
lectin
bind
specif
noncoval
protein
lipid
via
glycosyl
glycan
act
receptorlik
structur
allow
lectin
bind
directli
epitheli
cell
via
cytoadhes
result
transcytosi
larger
molecul
previou
studi
report
lectin
analyz
eg
erythrina
cristag
lectin
ecl
lycopersicon
esculentum
lectin
lel
wheat
germ
agglutinin
wga
bound
apic
membran
airway
epithelium
taken
endocytosi
wga
analyz
shown
cytoadhes
cytoinvas
properti
facilit
transport
highmolecularweight
molecul
lectin
bind
nacetylglucosamin
sialic
acid
improv
bind
uptak
proteinbas
drug
thu
approach
develop
function
nanomateri
studi
target
tissu
andor
cell
princip
receptor
receptor
overexpress
nanomateri
function
ligand
ie
antibodi
peptid
interact
receptor
addit
dual
ligand
also
use
achiev
synerget
effect
polysaccharidenanosystem
associ
well
sialyl
lewi
x
hyaluron
acid
ha
heparin
dextran
fucoidan
chitosan
cyclodextrin
ligand
contribut
local
drug
deliveri
stealth
enhanc
affin
stabil
aggreg
insid
cell
nanomateri
three
option
captur
endosom
consequ
degrad
lysosom
ii
escap
cytoplasm
iii
recycl
howev
nanomateri
must
escap
reach
intend
intracellular
target
thu
endosom
escap
crucial
intracellular
deliveri
drug
nanomateri
traffick
endosom
via
endolysosom
rout
earli
endosom
ph
matur
late
endosom
ph
fuse
lysosom
contain
particular
digest
enzym
fig
addit
endosom
traffick
matur
control
peptid
associ
ph
manipul
disper
drug
cytosol
endosom
lysi
protonspong
effect
transport
dissoci
product
pore
format
membran
disrupt
fusion
nanomateri
limit
membran
also
strategi
descib
escap
endosom
protonspong
effect
caus
acidif
via
transloc
proton
endosom
caus
osmosi
lysi
releas
content
polyaminebas
eg
pei
polym
pka
approxim
lead
increas
influx
ion
via
inflow
water
consequ
endosom
membran
ruptur
npendosom
membran
fusion
fusogen
lipid
incorpor
carrier
fusogen
lipid
compris
mainli
alanin
glycin
well
certain
hydrophob
residu
instanc
dope
acid
respons
acid
ph
drive
glutam
aspart
proton
result
new
hexagon
conform
facilit
insert
fusogen
lipid
juxtapos
membran
distroy
lipid
pack
pore
format
peptid
bind
ahel
structur
obliqu
insert
hydrophob
core
endosom
membran
stabil
transmembran
pore
orient
via
hydrophil
structur
howev
happen
membran
disrupt
instanc
peptid
bind
hydrophil
part
phospholipid
undergo
reorient
hydrophob
residu
result
amphipath
ahel
structur
allow
peptid
cover
membran
like
carpet
caus
disintegr
micel
membran
berguig
colleagu
creat
antibodypeptid
drug
conjug
suppress
tumor
growth
prolong
drug
half
life
lowdos
cytotox
polym
compris
two
block
first
improv
pharmacokinet
second
ph
respons
enabl
endosom
escap
incorpor
second
block
author
abl
form
micel
physiolog
ph
disrupt
membran
endosom
ph
promot
endosom
escap
intracellular
deliveri
first
block
exampl
includ
hydrophob
amino
acid
r
group
aid
viral
escap
endosom
ca
sirna
nanocomplex
electrotast
interact
lead
sirna
releas
cytoplasm
variant
result
threefold
improv
endosom
escap
via
membran
pore
addit
research
use
disulfidebond
dimer
tat
dftat
found
cytosol
nucleu
show
essenti
cell
penetr
also
membran
leakag
studi
erazoolivera
cowork
demonstr
dftat
interact
bi
monoacylglycero
phosphat
bmp
present
late
endosom
mediat
endosom
leakag
nanomateri
escap
endosom
enter
cytoplasm
exit
er
golgi
complex
cytoplasm
rout
gener
avoid
drug
must
enter
blood
circul
exert
pharmacolog
function
addit
difficulti
exit
cell
basolater
side
nanomateri
also
face
degrad
factor
enzym
cytoplasm
nanomateri
intracellular
destini
util
er
golgi
rout
well
retrograd
traffick
pathway
rout
respons
recycl
sever
molecul
pathway
receptor
endocytosi
endocytosi
involv
captur
transmembran
protein
extracellular
ligand
cytoplasm
vesicl
pinch
plasma
membran
beststudi
pathway
receptor
intern
mediat
clathrinco
pit
small
area
plasma
membran
cover
cytoplasm
surfac
clathrin
triskelion
compris
three
clathrin
heavi
chain
three
clathrin
light
chain
assembl
polyhedr
clathrin
lattic
receptor
recruit
clathrinco
pit
directli
interact
clathrin
coat
adaptor
complex
bind
adaptor
protein
turn
interact
clathrin
heavi
chain
andor
clathrinco
pit
invagin
inward
help
sever
accessori
protein
pinch
form
clathrinco
vesicl
process
requir
gtpase
dynamin
sever
clathrinindepend
pathway
endocytosi
also
exist
although
precis
mechan
structur
compon
involv
pathway
well
understood
endocyt
vesicl
deriv
clathrindepend
independ
endocytosi
fuse
earli
endosom
endosom
traffick
control
sever
rab
protein
small
gtpbind
protein
ra
superfamili
gtpbound
rab
protein
resid
particular
type
endosom
function
recruit
specif
effector
protein
follow
intern
earli
endosom
receptor
rapidli
recycl
back
plasma
membran
mechan
traffic
recycl
compart
contain
remain
endosom
matur
multivesicular
bodi
mvb
late
endosom
mvb
defin
presenc
intralumin
vesicl
ilv
form
inward
membran
invagin
involv
endosom
sort
complex
requir
transport
escrt
complex
earlytol
endosom
matur
involv
acquisit
remov
endosom
compon
capabl
necessari
recycl
mvb
cargo
destin
degrad
incorpor
ilv
fusion
late
endosom
mvb
lysosom
carri
proteolyt
enzym
result
cargo
degrad
reproduc
permiss
ref
receptor
target
golgi
complex
er
golgi
complex
import
secretori
endocyt
pathway
also
option
escap
acid
lysosom
environ
yu
colleagu
found
traffick
pathway
er
plasmat
membran
pm
pm
er
via
golgi
complex
traffick
control
retromermedi
endocyt
recycl
golgi
pathway
bind
class
receptor
enabl
intern
caveolaemedi
endocytosi
lipid
raftmedi
pathway
earli
endosom
nanocarri
content
deliv
er
golgi
complex
mitochondria
even
outsid
cell
present
transgolgi
network
tgn
earli
endosom
import
role
retrograd
traffick
tyrosinebas
sort
motif
regul
postgolgi
transport
deliveri
certain
compon
membran
inhibit
proport
decreas
caveolaemedi
endocytosi
thu
transport
lipid
class
depend
addit
also
interfer
retrograd
traffick
mannos
receptor
pancreat
b
cell
insulinrespons
membran
protein
endocrin
cell
lysosom
tgn
insulinrespons
compart
du
collabor
demonstr
movement
epiderm
growth
factor
receptor
egfr
golgi
complex
via
microtubuledepend
movement
fusion
complex
via
also
verifi
transloc
necessari
futur
fusion
nucleu
repres
pathway
cell
surfac
golgi
complex
even
nucleu
thu
pathway
would
prefer
nucleustarget
deliveri
rather
diffus
throughout
cytoplasm
final
step
drug
deliveri
process
import
given
crucial
ensur
drug
deliv
site
action
origin
pharmacodynam
bioavail
intact
deliv
drug
target
sever
intracellular
compon
fig
although
main
target
organel
nucleu
mitochondria
cytoplasm
er
golgi
complex
nucleu
organ
doublelay
lipid
envelop
nuclear
pore
complex
npc
size
nm
regul
flow
molecul
nucleu
underli
nuclear
lamina
practic
molecul
nm
molecular
weight
higher
kda
diffus
passiv
npc
larg
molecul
need
carrier
activ
pass
membran
nuclear
local
sequenc
nl
nl
present
sequenc
contain
basic
residu
prolyslyslysarglysv
recogn
importin
class
karyopherinb
protein
respons
nuclear
import
organel
control
dna
transcript
reproduct
metabol
cell
cycl
import
function
electron
transport
atp
synthesi
ro
gener
genet
program
cellular
signal
regul
also
affect
possibl
use
nanomateri
smaller
nucleu
pore
appli
posit
charg
nuclear
membran
establish
interact
nuclear
signal
even
use
molecul
high
affin
dna
tat
peptid
nucleu
crucial
role
treatment
heart
diseas
dystrophi
neurodegen
diseas
cancer
infect
gene
mutat
common
induc
nuclear
membran
permeabil
use
nanoma
possibl
intracellular
site
action
deliv
drug
figur
detail
main
target
organel
associ
diseas
characterist
relev
success
drug
intern
transport
nanomateri
commonli
use
drug
deliveri
definit
abbrevi
pleas
see
main
text
wwwdrugdiscoverytodaycom
terial
coat
molecul
recogn
nuclear
receptor
present
cytoplasm
eg
dexamethason
identifi
glucocorticoid
receptor
altern
way
interfer
dna
transcript
genet
program
variou
system
develop
gene
deliveri
common
way
target
nucleu
instanc
micel
two
synerget
anticanc
drug
coencapsul
havitamin
e
succin
intern
via
caveolaemedi
endocytosi
accumul
nucleu
cell
apoptosi
confirm
revers
multidrug
resist
via
target
plga
np
also
develop
coat
aptam
apt
load
superparamagnet
iron
oxid
np
spion
doxorubicin
dox
apt
use
target
nucleolin
nucleolin
protein
present
nucleu
import
role
angiogenesi
cell
prolifer
adhes
thu
combin
apt
dox
use
treatment
cancer
given
dna
intercal
agent
izeddin
et
al
develop
techniqu
track
protein
molecul
nucleu
determin
transcript
factor
tf
dynam
found
cmyc
ptefb
global
local
explor
nucleu
respect
control
tf
influenc
gene
regul
protein
reaction
function
nucleu
exploit
drug
develop
anoth
interest
approach
use
np
contain
pegbenzo
imineoligollysineiridium
iii
metallodrug
complex
phactiv
size
reduct
thu
ph
larg
protect
peg
shell
wherea
acid
ph
endosom
np
remain
small
dissoci
detach
peg
result
smaller
np
present
oligollysin
affect
nuclear
local
favor
transloc
nucleu
mitochondria
character
extern
membran
intermembran
space
intern
membran
rich
protein
mitochondri
matrix
dna
respons
cellular
homeostasi
thu
good
target
interfer
via
oxid
phosphoryl
apoptosi
product
ro
intracellular
signal
metabol
thu
unsurpris
mitochondria
contribut
obes
alzheim
diseas
neurodegener
cancer
diabet
mellitu
cardiomyopathi
given
polymorph
mutat
occur
mitochondri
dna
result
defici
energi
product
therefor
lipophil
posit
charg
requir
mitochondri
target
intern
neg
membran
potenti
organel
possibl
target
posit
charg
particl
mitochondriotrop
molecul
use
accumul
nanomateri
insid
cell
amphiphil
molecul
abil
escap
endosom
deliv
cargo
mitochondria
nanoformul
guid
mitochondri
process
proteinas
mpp
process
mitochondri
target
sequenc
mtss
dqa
mt
cdsezn
qd
mitoport
plgabpegtpp
lipophil
cation
potenti
method
use
approach
recent
mitochondria
target
cancer
cell
attempt
use
ha
protect
shell
encapsul
gold
nanostar
aun
dox
formul
shown
intern
via
receptor
coat
aun
triphenylphosphinemodifi
ahel
proapoptot
peptid
tppkla
local
mitochondria
interrupt
membran
induc
dysfunct
thu
apoptosi
folateco
chitosan
np
load
ursol
acid
also
propos
antibreast
cancer
drug
confirm
np
intern
via
folatereceptor
mediat
endocytot
pathway
destroy
permeabl
lysosom
membran
np
local
mitochondria
result
overproduct
ro
destroy
mitochondri
membran
potenti
caus
apoptosi
cancer
cell
sever
polymer
conjug
avail
especi
cancer
chitosan
also
use
reach
mitochondria
conjug
mitochondriatarget
ligand
triphenylphosphin
tpp
deliv
ionidamin
sirna
trigger
mitochondri
apoptosi
pathway
thu
appropri
way
target
mitochondria
metabol
pathway
coat
nanomateri
mitochondri
target
signal
andor
peptid
conjug
proapoptot
drug
er
organ
membran
structur
call
cisterna
separ
intermembran
space
organel
protein
fold
lipid
biosynthesi
occur
also
respons
control
drug
detoxif
apoptosi
immun
respons
signal
pathway
also
peptid
load
major
histocompat
complex
mhc
class
antigen
deliv
thu
act
present
site
protein
transport
mediat
kdel
sequenc
work
local
signal
recogn
receptor
kdelr
express
er
thu
er
appropri
pharmaceut
target
use
biomimet
approach
anoth
method
er
target
use
local
signal
antibodi
er
receptor
lead
er
stress
protein
misfold
aggreg
calcium
homeostasi
disturb
exposur
free
radic
associ
er
dysfunct
infecti
proteinfold
diseas
diabet
neurodegener
cardiovascular
diseas
murugan
colleagu
develop
mesopor
silica
np
pore
load
topotecan
coat
poli
acryl
acid
chitosan
conjug
quercetin
approach
result
breast
cancer
cell
death
structur
chang
organel
er
nucleu
mitochondria
treatment
diabet
imag
use
two
photon
fluoresc
probe
erbzt
follow
treatment
metformin
propos
given
product
ro
lead
er
stress
diseas
format
found
natur
compound
jaceosidin
contribut
sarcoer
ca
atpas
upregul
decreas
er
stress
target
liposom
er
phospholipid
kdel
sequenc
kdelr
antibodi
review
elsewher
intracellular
deliveri
nanomateri
target
organel
compris
system
tubular
membran
orient
ci
tran
direct
main
function
golgi
complex
oglycosyl
protien
transport
sort
addit
influenc
lipid
biosynthesi
tgn
center
endocyt
exocyt
pathway
import
role
straighten
lipid
protein
normal
associ
er
given
differ
cargo
transport
cisgolgi
network
tng
cargo
sort
forward
destin
matsuto
colleagu
demonstr
enabl
bind
golgi
complex
also
show
respons
fusion
golgi
tubul
er
retrograd
traffick
unsurpris
golgi
complex
dysfunct
contribut
variou
diseas
alzheim
cancer
neurodegen
diseas
diabet
golgi
complextarget
signal
discov
coronaviru
respons
sever
acut
respiratori
syndrom
shown
cytoplasm
tail
betahairpin
structur
motif
control
golgi
complex
local
exploit
motif
could
way
improv
target
golgi
complex
banfield
also
describ
sever
mechan
protein
retent
golgi
complex
kin
recognit
transmembran
domainmedi
amino
acid
sequenc
motif
could
also
target
drug
deliveri
cytoplasm
intracellular
space
contain
variou
organel
target
way
reach
specif
organel
howev
term
latter
drug
diffus
interact
randomli
organel
instanc
sirna
act
cytoplasm
nanomateri
high
metabol
stabil
slap
deliv
cytoplasm
inhibit
cell
receptor
use
treatment
autoimmun
diseas
typic
organel
target
infecti
autoimmun
diseas
famili
hypercholesterolemia
occur
sever
approach
avail
allow
deliveri
nanomateri
cytoplasm
cpp
cation
nanomateri
liposom
fusogen
properti
ph
sensit
also
studi
drug
carrier
given
abil
destabil
endosom
membran
releas
drug
cytoplasm
use
polyampholyt
np
freez
concentr
suggest
deliv
protein
cytoplasm
applic
fade
electr
treatment
sirna
deliveri
via
connectosom
diffus
across
tj
bubbl
liposom
ultrasound
enzymesensit
redoxrespons
linker
respons
degrad
cell
membran
also
report
given
nanomateri
paramet
describ
ideal
rout
deliveri
remain
oral
rout
current
drug
approv
nanopharmaceut
review
exampl
intracellular
applic
ferahem
tm
ferumoxytol
approv
us
food
drug
administr
fda
treat
iron
defici
anemia
adult
chronic
kidney
diseas
nanopharmaceut
compris
spion
coat
dextran
iron
releas
insid
macrophag
ad
intracellular
storag
iron
pool
transfer
plasma
transferrin
plegridi
biogen
polymerprotein
conjug
pegyl
ifn
improv
protein
stabil
due
pegyl
approv
treatment
multipl
sclerosi
drug
bind
type
interferon
receptor
surfac
cell
caus
intracellular
event
lead
regul
interferonrespons
gene
express
similarli
onivyd
liposom
irinotecan
approv
fda
treat
pancreat
cancer
increas
intracellular
uptak
irinotecan
reduc
system
toxic
aris
advers
effect
wwwfdagov
challeng
strategi
enhanc
intracellular
deliveri
nanomateri
definit
abbrevi
pleas
see
main
text
wwwdrugdiscoverytodaycom
function
nanomateri
current
appropri
success
way
drug
reach
specif
target
reduc
advers
effect
increas
effici
howev
sever
paramet
must
taken
account
size
charg
composit
shape
correl
cell
uptak
long
circul
time
renal
clearanc
drug
stabil
discuss
variou
obstacl
must
overcom
success
drug
deliveri
culmin
final
step
character
endosom
escap
organel
locat
membran
transloc
drug
requir
deliveri
specif
organel
increas
deliveri
challeng
evid
organel
dysfunct
origin
sever
diseas
therefor
one
treatment
strategi
target
set
organel
reach
desir
therapeut
effect
futur
nanoformul
aim
exploit
success
approach
describ
result
safe
effect
target
drug
deliveri
detail
fig
ideal
nanoformul
would
posit
surfac
charg
ligand
affin
improv
endocytosi
enabl
follow
retrograd
pathway
avoid
lysosom
degrad
escap
endosom
final
biomimet
strategi
could
way
improv
intracellular
transport
andor
exocytosi
nevertheless
requir
better
understand
mechan
underli
intracellular
transport
integr
nanomateri
drug
releas
